Inicio › Cáncer metastásico › Carolina del Norte › Durham
Ensayos clínicos de Cáncer metastásico en Durham, NC
33 estudios para Cáncer metastásico buscan participantes en centros de Durham y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
ReclutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Chapel Hill · A 10 mi de distancia
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Duke University Medical Center, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- Duke University, Durham
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
ReclutandoFase 2/3
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · A 10 mi de distancia
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ReclutandoFase 2
- Duke Cancer Institute, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutandoFase 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · A 10 mi de distancia
- University of North Carolina Hospitals at Hillsborough, Hillsborough · A 13 mi de distancia
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutandoFase 3
- Duke Cancer Institute, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- University of North Carolina Medical Center, Chapel Hill · A 10 mi de distancia
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · A 10 mi de distancia
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ReclutandoFase 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · A 10 mi de distancia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Duke University, Durham
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Reclutando
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · A 10 mi de distancia
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
ReclutandoFase 1
- Duke Cancer Center, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Research Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
ReclutandoFase 1
- Research Site, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
ReclutandoFase 1
- Duke Cancer Center, Durham
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
ReclutandoFase 1/2
- Duke University Medical Center, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
ReclutandoEstudio observacional
- University of North Carolina at Chapel Hill, Chapel Hill · A 10 mi de distancia
UNC Metastatic Cancer Radiation Therapy Registry
ReclutandoEstudio observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · A 10 mi de distancia
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
ReclutandoFase 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · A 10 mi de distancia
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
ReclutandoFase 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ReclutandoFase 2/3
- Duke University Medical Center, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
ReclutandoFase 1/2
- Duke Cancer Center/ DUMC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutandoFase 1
- Duke Cancer Institute, Durham
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
ReclutandoFase 3
- Duke University, Durham
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
ReclutandoEstudio observacional
- Durham Veterans Administration Health Care System (DVAHCS), Durham
- Duke University Medical Center, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
ReclutandoFase 1
- Duke Cancer Center, Durham
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
ReclutandoFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · A 10 mi de distancia
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- Duke University Medical Center - Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Chapel Hill · A 10 mi de distancia
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
ReclutandoFase 3
- Duke University - Trent Center, Durham
A Study of NX-1607 in Adults With Advanced Malignancies
ReclutandoFase 1
- University of North Carolina, Chapel Hill · A 10 mi de distancia
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en Durham
- Cáncer de seno64 estudios
- Cáncer (todos los tipos)58 estudios
- Cáncer de pulmón de células no pequeñas39 estudios
- Mieloma múltiple37 estudios
- Leucemia mielógena aguda33 estudios
- Cáncer de próstata32 estudios
- Cáncer de pulmón32 estudios
- Cáncer del colon y del recto28 estudios
- Cáncer de ovario27 estudios
- Leucemia linfocítica crónica27 estudios
- Fallo cardíaco26 estudios
- Cáncer de páncreas24 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.